scholarly journals Soy Consumption, Markers of Inflammation, and Endothelial Function: A cross-over study in postmenopausal women with the metabolic syndrome

Diabetes Care ◽  
2007 ◽  
Vol 30 (4) ◽  
pp. 967-973 ◽  
Author(s):  
L. Azadbakht ◽  
M. Kimiagar ◽  
Y. Mehrabi ◽  
A. Esmaillzadeh ◽  
F. B. Hu ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Endothelial Function ◽  
Postmenopausal Women ◽  
Markers Of Inflammation ◽  
The Metabolic Syndrome

Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome

Maturitas ◽  
2014 ◽  
Vol 77 (4) ◽  
pp. 370-374 ◽  
Author(s):  
Peter Chedraui ◽  
Gustavo S. Escobar ◽  
Faustino R. Pérez-López ◽  
Giulia Palla ◽  
Magdalena Montt-Guevara ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Endothelial Function ◽  
Postmenopausal Women ◽  
The Metabolic Syndrome

scholarly journals Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome

Circulation ◽  
2005 ◽  
Vol 111 (3) ◽  
pp. 343-348 ◽  
Author(s):  
Srikanth Sola ◽  
Muhammad Q.S. Mir ◽  
Faiz A. Cheema ◽  
Nadya Khan-Merchant ◽  
Rekha G. Menon ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Endothelial Function ◽  
Lipoic Acid ◽  
Markers Of Inflammation ◽  
The Metabolic Syndrome

The Role of Quinapril in the Presence of a Weight Loss Regimen: Endothelial Function and Markers of Obesity in Patients With the Metabolic Syndrome

2007 ◽  
Vol 10 (4) ◽  
pp. 204-209 ◽  
Author(s):  
Sameer Nagamia ◽  
Anbu Pandian ◽  
Faiz Cheema ◽  
Rama Natarajan ◽  
Qamar A. Khan ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Weight Loss ◽  
Endothelial Function ◽  
The Metabolic Syndrome

The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women

2017 ◽  
Vol 34 (1) ◽  
pp. 78-82 ◽  
Author(s):  
Irene Lambrinoudaki ◽  
Aikaterini Kazani ◽  
Eleni Armeni ◽  
Demetrios Rizos ◽  
Areti Augoulea ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Arterial Stiffness ◽  
Postmenopausal Women ◽  
Carotid Atherosclerosis ◽  
The Metabolic Syndrome

Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome

Maturitas ◽  
2014 ◽  
Vol 79 (1) ◽  
pp. 86-90 ◽  
Author(s):  
Peter Chedraui ◽  
Faustino R. Pérez-López ◽  
Gustavo S. Escobar ◽  
Giulia Palla ◽  
Magdalena Montt-Guevara ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Postmenopausal Women ◽  
The Metabolic Syndrome

The WHO and NCEP/ATPIII Definitions of the Metabolic Syndrome in Postmenopausal Women: Are They So Different?

2006 ◽  
Vol 4 (1) ◽  
pp. 17-27 ◽  
Author(s):  
Marie-Ève Piché ◽  
S. John Weisnagel ◽  
Louise Corneau ◽  
André Nadeau ◽  
Jean Bergeron ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Postmenopausal Women ◽  
The Metabolic Syndrome

scholarly journals The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease

2019 ◽  
Vol 105 (5) ◽  
pp. e2050-e2060 ◽  
Author(s):  
Jennifer L Gordon ◽  
David R Rubinow ◽  
Lana Watkins ◽  
Alan L Hinderliter ◽  
Melissa C Caughey ◽  
...  
Keyword(s):  
Endothelial Function ◽  
Postmenopausal Women ◽  
Baroreflex Sensitivity ◽  
Stress Reactivity ◽  
Arterial Disease ◽  
The Metabolic Syndrome ◽  
Early Postmenopausal Women ◽  
Age Related ◽  
Transdermal Estradiol ◽  
Micronized Progesterone

Abstract Background The arterial effects of hormone therapy remain controversial. This study tested the effects of transdermal estradiol plus intermittent micronized progesterone (TE + IMP) in healthy perimenopausal and early postmenopausal women on several mechanisms involved in the pathophysiology of arterial disease. Methods Healthy perimenopausal and early postmenopausal women, ages 45 to 60 years, were enrolled in this randomized, double-blind, placebo-controlled trial. Women were randomized to receive TE (0.1 mg/day) + IMP (200 mg/day for 12 days) or identical placebo patches and pills for 12 months. Outcomes included: change in stress reactivity composite z-score (combining inflammatory, cortisol, and hemodynamic responses to a standardized psychological laboratory stressor); flow-mediated dilation (FMD) of the brachial artery (an index of vascular endothelial function); baroreflex sensitivity; and metabolic risk (presence of the metabolic syndrome or insulin resistance), all assessed at baseline and at months 6 and 12. Results Of 172 women enrolled, those assigned to TE + IMP tended to have higher resting baroreflex sensitivity than those assigned to placebo across the 6- and 12-month visits. Although treatment groups did not differ in terms of the other prespecified outcomes, a significant treatment-by-age interaction was found for FMD and stress reactivity such that an age-related decrease in FMD and increase in stress reactivity were seen among women assigned to placebo but not those assigned to TE + IMP. Women on TE + IMP also had lower resting diastolic blood pressure, lower levels of low-density lipoprotein cholesterol, and higher baroreflex sensitivity during stress testing. Conclusions TE + IMP tended to improve cardiac autonomic control and prevented age-related changes in stress reactivity and endothelial function among healthy perimenopausal and early postmenopausal women.

Sign in / Sign up

Export Citation Format

Share Document